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This study evaluated the safety of Lafoensia pacari A. St.-Hil. (Lythraceae) stem bark 
hydroalcoholic extract (LPE) through acute and subchronic toxicological assessments in mice. 
In the acute toxicity evaluation, a single 2000 mg/kg oral dose of LPE was administered to 
mice and clinical observations were conducted for 14 days. For subchronic toxicity, LPE doses  
(6.25-1000 mg/kg) were administered orally for 28 days and biochemical, hematological, histopathological 
analyses and renal and liver expression of Ki-67 were carried out. The acute oral toxicity evaluation of 
LPE showed no toxicity in mice and it was was classified as category 5 (LD50>2000-5000 mg/kg). In a 
repeated dose 28-day toxicity study, LPE (100-1000 mg/kg) led to an increase in reticulocytes, which 
suggests a possible proliferative effect on blood cells. In addition, LPE (400-1000 mg/kg) of produced 
alterations in biochemical parameters, although no microscopic changes were found in the organs 
analyzed. A normal expression of the Ki-67 cell proliferation indicator was observed in the kidney and 
liver tissues, which suggests that LPE does not bring about changes in the proliferative activity of these 
organs. In conclusion, LPE should be used with caution, particularly in larger doses over longer periods 
and also in combination with other medication.
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INTRODUCTION
Lafoensia pacari A. St.-Hil. (Lythraceae), popularly 
known as mangava-brava or pacari, is a medicinal plant 
found in the Cerrado biome, the Brazilian savanna. Its 
stem bark has been used to treat gastric ulcers, cancer, 
diarrhea, kidney diseases and inflammatory processes 
in Brazilian popular medicine (Proença, Oliveira, 
Silva, 2000; Solon et al., 2000; Lima et al., 2006a; 
Nascimento et al., 2011).
Phytochemical analyses carried out on Lafoensia 
pacari stem bark hydroalcholic extract (LPE) have 
demonstrated the presence of tannins, saponins, steroids, 
triterpenes and flavonoids (Galdino et al., 2009; 2015). 
In addition, several other phytochemicals have been 
identified in hydroalcoholic extract preparations, as well 
as their organic fractions, such as chalcones, aurones, 
free xanthones, heterosides, leucoanthocyanidins, 
anthraquinones, 3-O-β-D-glucopyranoside, gallic acid and 
ellagic acid, which is the main active compound of this 
plant (Solon et al., 2000; Lima et al., 2006b; Rogerio et al., 
2006; Galdino et al., 2009; 2015; Nascimento et al., 2011; 
Sampaio et al., 2011; Tamashiro Filho et al., 2012).
Scientific studies have corroborated the popular 
use of L. pacari stem bark as an anti-inflammatory agent 
(Rogerio et al., 2006; Matos et al., 2008; Rogerio et al., 
2008a) through the inhibition of inflammatory parameters 
such as interleukin-5 and eosinophil  migration 
(Rogerio et al., 2003; 2008b; Rogerio, Sá-Nunes, Faccioli, 
2010). In vivo studies have also reported antiulcer activity, 
associated, at least in part, with two different mechanisms: 
a dependent mechanism of the antioxidant and anti-
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secretory properties and inhibition of pro-inflammatory 
cytokines; and an independent mechanism of gastric/
intestinal motility and mucus secretion (Tamashiro 
Filho et al., 2012). Certain studies have also highlighted 
other significant activities, which include in vitro free 
radical scavenging (Solon et al., 2000), anticancer 
(Marcondes et al., 2014) and antimicrobial potential 
(Lima et al., 2006a; 2006b; Silva Junior et al., 2010; 
Pereira et al., 2011; Queiroz e Silva et al., 2012). 
In addition, analgesic and anti-oedematous effects 
(Rogerio et al., 2006), antidepressant-like activity 
(Galdino et al., 2009; 2015), sedating (Matos et al., 2008), 
antinociceptive effects, independent of anti-inflammatory 
activity (Matos et al., 2008; Nascimento et al., 2011) and 
wound healing effect (Pereira et al., 2018) have been 
shown. 
Despite the above-mentioned scientific evidence, 
and the use of the L. pacari stem bark hydroalcoholic 
extract (LPE) in Brazilian popular medicine, the toxicity 
data on this plant are still scarce. With that in mind, this 
study evaluated the safety of LPE, through acute oral 
systemic toxicity and repeated dose 28-day toxicity 
studies in mice, since the most L. pacari preparations 
used by Brazilians are made using stem bark maceration 
in alcoholic preparations (Galdino et al., 2015).
MATERIAL AND METHODS
Obtaining LPE
The stem bark was collected from L. pacari 
plants in Bela Vista, State of Goiás, Brazil (837 m, 
16°58’54.2” S, 40°55’45.1” W). The botanical material 
was authenticated by Dr. José Realino de Paula, and a 
voucher specimen was deposited at the Federal University 
of Goiás Herbarium (UFG no. 27031). LPE was obtained 
as previously described by Nascimento et al. (2011). In 
brief, the LPE was obtained through drying of stem bark 
pieces at 30-40 °C for 48 h and powdered. After that, 
it was carried out maceration in a 70% hydroalcoholic 
solution for 72 h and subsequent filtration. The solvent 
was then evaporated until dry under reduced pressure, 
giving extract with a yield of 16.1% (w/w). In a previously 
published study, phytochemical analysis of LPE showed 
the presence of total phenols (18.9%), flavonoids (4%) 
and total tannins (16.7%), being ellagic acid one of the 
phytochemicals present in the extract (Nascimento et al., 
2011). The doses of LPE were immediately prepared by 
dilution in sunflower oil (vehicle) before administering to 
the animals, as recommended by OECD (2002).
Animals 
The experimental protocols were approved by the 
Federal University of Goiás Research Ethics Committee 
for the Use of Animals (UFG Nº 137/2009), in accordance 
with institutional procedures and guidelines of the 
Institutional Animal Care and Use Committee, which 
follows the recommendations of the Canadian Council 
on Animal Care (Olfert, Cross, Mcwilliam, 1993). Swiss 
male and female mice (body weight: 25-35 g; age: 
7-10 weeks) were obtained from the Bioterium at the 
Federal University of Goiás. All efforts were realized 
to ensure the welfare of animals. They were kept in 
constant environmental conditions with light-dark 
cycles and controlled temperature, and water and food 
were provided ad libitum. There were daily checks of 
changes in activity and behavior as a clinical indication 
of animal suffering to determine when they should be 
humanely sacrificed (Hubrecht, Kirkwood, 2010). At the 
end of each experiment, the mice were anesthetized with 
intraperitoneally administered xylazine (10 mg/kg) and 
ketamine hydrochloride (100 mg/kg) and then euthanized 
by cervical dislocation (Hubrecht, Kirkwood, 2010).
Toxicity studies
Acute toxicity evaluation of LPE
The acute oral toxicity of LPE was investigated 
according to OECD Guideline 423 (2002). This guideline 
recommends an alternative acute toxic class method 
focused on reducing animals use without reducing the 
scientific integrity of data obtained. Male and female mice 
(n=3/group/sex) were randomly separated into control and 
treated groups. After three hours of food fasting, a single 
2000 mg/kg dose of LPE (0.2 mL) was administrated 
orally (gavage) to each animal. The control group only 
received LPE vehicle (sunflower oil) (0.2 mL). After 
exposure, clinical observations were conducted at 5, 15 
and 30 min, and every hour up to the twelfth hour of the 
first day. Posteriorly, the mice were examined once a day 
for an additional 13 days. The safety of the 2000 mg/kg 
dose of LPE was subsequently confirmed in other male and 
female mice as recommended by OECD Guideline 423.
Subchronic toxicity evaluation of LPE 
Female mice were used in the subchronic toxicity 
test based on OECD Guideline 407 – Repeated Dose 
28-day Toxicity Study in Rodents (2008). The animals 
were randomly divided into five groups (n=5/group) and, 
after three hours of food fasting, they were treated daily 
with vehicle (sunflower oil) or doses of LPE (6.25, 25, 
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100, 400 or 1000 mg/kg). The extract and its vehicle were 
administered orally. During the test, the animals were 
observed daily and weighed weekly to adjust the dose 
when needed. After exposure, the mice were anesthetized 
and approximately 1 mL of blood was removed by cardiac 
puncture. The animals were immediately euthanized. 
Aliquots of blood samples were divided between a tube 
without anticoagulants and another containing EDTA 
for biochemical and hematological assays, respectively. 




A hematological examination was undertaken using 
an ABX Micros 60 apparatus (Horiba, São Paulo, SP, 
Brazil). The parameters analyzed were red blood cells, 
hemoglobin, hematocrit, platelets and global leukocytes. 
Reticulocyte counting was also determined using brilliant 
cresyl blue dye (Nakage et al., 2005). To prepare the 
slides, 50 µL of the blood of each animal was incubated 
with the same amount of dye for 15 minutes at 37 °C. 
Then the number of reticulocytes per 1000 erythrocytes 
was determined microscopically (1000x magnification) 
in a blind test. A reticulocyte was identified as a red 
blood cell containing at least two granules of reticulum 
(Lamchiagdhase, Pattanapanyasat, Muangsup, 2000).
Biochemical analysis
Blood samples without anticoagulants were 
centrifuged to obtain a serum pool, which was submitted 
to a biochemical examination. The following biochemical 
parameters were employed using LabmaxPlenno 
(Labtest, Belo Horizonte, MG, Brazil) equipment: alanine 
aminotransferase (ALT), aspartate aminotransferase 
(AST), urea, creatinine, albumin, total cholesterol 
and proteins, while the electrolytes (Na+ and K+) were 
evaluated using AVL 9180 Electrolyte Analyzer (Instru-
Med, Atlanta, GA, USA). 
Necropsy and histopathology
A gross necropsy was conducted by visual inspection 
of all animals at the end of the treatment period. The 
following organs were collected, weighed and evaluated 
in terms of body weight percentage of each animal: 
brain, kidney, liver, heart, spleen and lung. These tissues 
were preserved in 10% buffered formalin to await the 
histopathological analysis.
For the histopathology evaluation, macroscopic 
cross sections of these organs were dehydrated in graded 
ethanol (70-100%), cleared in xylene and then paraffin-
embedded. Paraffin-embedded tissue sections of 5 µm 
thickness were obtained using a microtome (Leica RM 
2155, Heidelberg, BW, Germany). After mounting, the 
slides were dewaxed in xylene, hydrated using graded 
ethanol and stained with hematoxylin and eosin (H&E). 
The sections were observed with a light microscope (Axio 
Scope A1 Carl Zeiss, Jena, TH, Germany) using a 40x 
objective and photographed using an AxioCam MRc Carl 
Zeiss camera and AxioVs40 V 4.7.2.0 Carl Zeis software.
Immunohistochemistry for detecting Ki-67
Paraffin-embedded liver and kidney sections of 3 µm 
thickness were obtained and mounted on silane-coated 
microscope slides for immunohistochemistry to detect 
Ki-67 as described by Ávila et al. (2015).
Statistical analysis
The data were expressed as mean ± standard 
deviation. Inter group variation was measured by 
the Analysis of Variance (ANOVA) followed by the 
Bonferroni test. Statistical significance was established 
as p<0.05.
RESULTS
Acute oral toxicity evaluation of LPE
In the acute toxicity assay, the experimental groups of 
male and female mice were exposed to a single 2000 mg/kg 
dose of the LPE. During the 14 days after evaluation, only one 
female mouse appeared apathetic and died. The safety of this 
dose was subsequently defined through another experiment 
and no death or clinical signs of toxicity were observed in 
the mice. Thus, the DL50 of LPE was classified as category 5 
(LD50 > 2000 - 5000 mg/kg) of the Globally Harmonized 
Classification System for Chemical Substances and 
Mixtures (GHS), in agreement with OECD Guideline 423 
(2001). For the subsequent assay of subchronic toxicity 
assessment, females were used because of their possible 
susceptibility to LPE.
Subchronic toxicity evaluation of LPE
During the 28-day subchronic toxicity assay, neither 
death nor clinical signs of toxicity in the mice exposed to 
LPE (6.25, 25, 100, 400 or 1000 mg/kg) were observed. 
Moreover, no significant abnormality in feces, hair, body 
weight loss or behavior was identified in comparison with 
the control group. 
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In terms of the hematological analysis, the 
percentage of reticulocytes showed a significant 
increase for the higher doses of LPE, at 100, 400 and 
1000 mg/kg (p<0.05). The other parameters did not show 
any significant alterations for any of the extract doses 
(Table I).
The biochemical parameters of the pooled serum are 
summarized in Table II. In animals treated with the three 
lower doses of LPE (6.25, 25 and 100 mg/kg), the levels 
of total cholesterol, and hepatic and renal biomarkers 
were similar to those of the control values. On the other 
hand, the animals treated with 400 and 1000 mg/kg of LPE 
showed a tendency towards increase in levels of AST, ALT 
(especially at 1000 mg/kg), total proteins, albumin, urea 
and total cholesterol, while creatinine showed a tendency 
towards reduction when compared to those of the control 
values. In parallel, K+ electrolyte levels were similar 
to those of the control group, whereas Na+ levels were 
normal at lower doses. However, with doses of 400 and 
1000 mg/kg, the levels of these electrolytes were reduced.
As regards organ weight analysis, only animals 
treated with 1000 mg/kg of LPE showed a significant 
reduction in liver weight (p<0.001), while for the 
other organs analyzed (brain, kidney, heart, spleen and 
lung) no changes were observed in the groups treated 
when compared to the control (Table III). In addition, 
macroscopy and histopathology evaluation presented 
no abnormality in organs of the groups treated. These 
included the kidney and liver, the two major organs of 
metabolism and excretion of xenobiotics. In these, no 
changes were observed in the Ki-67 expression, which 
shows that the LPE probably did not alter renal or hepatic 
proliferative activity (Figure 1).
DISCUSSION
Several studies have highlighted the medicinal 
properties of L. pacari, corroborating its use in popular 
medicine. Phenolic compounds (e.g. flavonoids and 
tannins, and in particular the main active compound of LPE, 
TABLE I - Effects of daily oral treatment of female mice with LPE (6.25, 25, 100, 400 or 1000 mg/kg/day) during 28 days in 
the hematological parameters












Control 4.54 ± 0.64 1.66 ± 0.39 6.31 ± 0.46 21.94 ± 2.86 404.44 ± 41.73 4.54 ± 0.64
6.25 mg/kg 4.68 ± 0.19 2.0 ± 0.20 6.35 ± 0.37 22.98 ± 1.21 456.0 ± 42.0 4.68 ± 0.19
25 mg/kg 5.19 ± 0.23 2.10 ± 0.20 6.76 ± 0.47 24.70 ± 1.52 396.20 ± 70.96 5.19 ± 0.23
100 mg/kg 4.54 ± 0.25 2.75 ± 0.07a 6.15 ± 0.43 21.30 ± 1.15 430.25 ± 66.75 4.54 ± 0.25
400 mg/kg 4.10 ± 0.31 2.60 ± 0.53a 6.14 ± 0.39 19.66 ± 1.23 339.0 ± 64.0 4.10 ± 0.31
1000 mg/kg 4.66 ± 0.29 2.85 ± 0.30a 5.85 ± 0.28 22.63 ± 1.08 368.33 ± 117.88 4.66 ± 0.29
The data are expressed as the mean ± standard deviation of five animals. ap<0.05 vs. control. One-way ANOVA and Bonferroni’s test.
TABLE II - Evaluation of serum pool biochemical parameters after daily oral treatment of female mice with LPE (6.25, 25, 100, 
400 or 1000 mg/kg/day) during 28 days












Control 34 201.5 2.3 5.8 50.5 0.33 5.0 161 90
6.25 mg/kg 34 218 2.1 5.6 51 0.35 * * 98
25 mg/kg 32 183 1.9 5.1 45 0.33 4.8 168 74
100 mg/kg 41 184 2.2 5.8 56 0.36 5.5 172 94
400 mg/kg 51 210 2.9 7.3 57 0.31 5.6 152 125
1000 mg/kg 43 309 2.6 6.7 64 0.21 5.1 152 122
Data represent the analysis of a sample pool, since the reduced amount of serum obtained. The asterisk (*) represents electrolyte 
levels not detected in the sample
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TABLE III - Relative organ weights of female mice after daily oral treatment with LPE (6.25, 25, 100, 400 or 1000 mg/kg/day) 
during 28 days
Groups Brain (%) Kidney (%) Liver (%) Heart (%) Spleen (%) Lung (%)
Control 1.31 ± 0.12 1.10 ± 0.04 4.68 ± 0.26 0.61 ± 0.19 0.33 ± 0.04 0.84 ± 0.16
6.25 mg/kg 1.43 ± 0.05 1.06 ± 0.06 4.80 ± 0.19 0.42 ± 0.02 0.38 ± 0.09 0.95 ± 0.31
25 mg/kg 1.30 ± 0.10 1.12 ± 0.06 4.56 ± 0.24 0.44 ± 0.03 0.37 ± 0.05 0.92 ± 0.15
100 mg/kg 1.25 ± 0.15 1.03 ± 0.07 4.71 ± 0.14 0.55 ± 0.11 0.36 ± 0.05 0.82 ± 0.06
400 mg/kg 1.21 ± 0.16 1.0 ± 0.07 4.39 ± 0.32 0.49 ± 0.04 0.29 ± 0.03 0.97 ± 0.16
1000 mg/kg 1.50 ± 0.10 1.01 ± 0.06 4.15 ± 0.17a 0.59 ± 0.16 0.25 ± 0.04 0.86 ± 0.10
Data are expressed as the mean ± standard deviation of five organs animals. ap<0.001vs. control. Two-way ANOVA and Bonferroni 
test.
FIGURE 1 - Histopathology and Ki-67 detection representative photomicrographs of kidney and liver sections of mice treated 
orally with LPE (6.25, 25, 100, 400 or 1000 mg/kg/day) for 28 days.
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ellagic acid) have been shown to be fundamental for the 
biological activities found in L. pacari (Solon et al., 2000, 
Sampaio et al., 2011). However, no toxicity studies had 
been well conducted to demonstrate the safety of this plant.
In the first observation of this study, the acute oral 
systemic toxicity evaluation of a single 2000 mg/kg dose 
of LPE showed no toxicity in either the male or female 
mice studied. Thus, the DL50 of LPE was classified as GHS 
category 5 (LD50 > 2000 - 5000 mg/kg), as proposed by 
the OECD evaluation criteria (2002). Although products 
classified in this category are commonly considered as 
having low acute toxicity, continued use can produce 
different biological effects and therefore should be 
investigated. In this regard, a repeated dose 28-day toxicity 
study of LPE (6.25, 25, 100, 400 or 1000 mg/kg) was 
evaluated through clinical, biochemical, histopathological/
immunocytochemical and hematological analyses to 
examine possible toxic effects in tissues, specifically 
hepatic and renal effects (OECD, 2008). 
The results indicated that a daily oral administration 
of 6.25, 25 or 100 mg/kg of LPE for 28 days did not alter 
the biochemistry, hematology or organs of the animals 
exposed. In addition, the data suggested that 400 and 
1000 mg/kg of LPE induced alterations in the biochemical 
parameters of the animals, especially in transaminase 
levels, hematological parameters and in liver weight. 
However, these two higher doses do not represent the 
amount commonly used in folk medicine and, in this study, 
they only illustrate an overdose condition, as recommended 
by OECD (2008). In a study of the therapeutic assessment 
of LPE in the eradication of Helicobacter pylori, capsules 
with 500 mg powder of 20% methanolic extract of 
L. pacari were orally administered twice a day for 14 days 
to patients with dyspeptic complaints and positive for 
H. pylori. This treatment did not eradicate H. pylori; 
however, it was well-tolerated and individuals reported 
relief of symptoms (Menezes et al., 2006).
Macroscopic evaluations of the organs of animals 
treated with LPE (6.25-1000 mg/kg) did not show any 
alteration. Furthermore, no change was observed in the 
expression of the Ki-67 cell proliferation indicator in 
the kidney or liver tissues, which suggests that LPE did 
not promote changes in the proliferative activity of these 
organs. Several studies have reported the protective effects 
of ellagic acid, the main active compound responsible for 
the biological effects of LPE, and of other Lythraceae 
family species on liver (Baravalia, Chanda, 2011; García-
Niño, Zazueta, 2015; Kang et al., 2016; Salem et al., 2016) 
and kidney (Priya, Sabu, Jolly, 2007; Basha, Saumya, 
2013; El-Garhy et al., 2014; Ayhanci et al., 2015) injuries 
triggered by xenobiotic-induced oxidative stress.
In terms of the hematological analysis, animals 
treated with 100, 400 and 1000 mg/kg of LPE showed a 
significant increase in reticulocytes, which demonstrates 
a possible proliferative effect on blood cells. In another 
study, Lima et al. (2013) presented the antigenotoxic and 
anticytotoxic activities of LPE on reticulocytes obtained 
from mouse bone marrow through the micronucleus 
assay. Corroborating these findings, Grossi et al. (2014) 
also showed that ellagic acid did not reveal any negative 
effect on the bone marrow hematopoietic cells. Moreover, 
a 90-day subchronic toxicity study showed no mortality, 
clinical signs, biochemical or histopathological changes 
in F344 male or female rats treated with different doses of 
ellagic acid (Tasaki et al., 2008).
In conclusion, the acute oral toxicity evaluation of 
the LPE showed no toxicity in either female or male mice, 
showing LD50 (> 2000 - 5000 mg/kg) classified as GHS 
category 5. In addition, the results indicate that a daily 
oral administration of two higher doses of LPE (400 and 
1000 mg/kg) for 28 days did not produce hematotoxicity, 
but biochemical alterations in the liver and renal function, 
without any macroscopic/microscopic or proliferative 
changes, were found. In view of the fact that there is no 
scientific knowledge about the toxicological profile of the 
L. pacari plant, it should be used with caution, particularly 
in larger doses over longer periods and also in combination 
with other medication.
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